Sophistication of foldamer form and function in vitro and in vivo

Current Opinion in Chemical Biology

Volumn 11, Issue 6, 2007, Pages 685-692

  Bautista, Arjel D ^a   Craig, Cody J ^a   Harker, Elizabeth A ^a   Schepartz, Alanna ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; PENETRATIN; PEPTIDE DERIVATIVE; PEPTOID; PROTEIN P53; SCAFFOLD PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL MEMBRANE PERMEABILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CELL LINE; HUMANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PEPTIDES; POLYMERS;

EID: 36549088592     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2007.09.009     Document Type: Review

References (74)

1. Kabouridis P.S. Biological applications of protein transduction technology. Trends Biotechnol 21 (2003) 498-503
2. Tung C.-H., and Weissleder R. Arginine containing peptides as delivery vectors. Adv Drug Delivery Rev 55 (2003) 281-294
3. Fernandez-Carneado J., Kogan M.J., Pujals S., and Giralt E. Amphipathic peptides and drug delivery. J Pept Sci 76 (2004) 196-203
4. Fuchs S., and Raines R. Internalization of cationic peptides: the road less (or more?) traveled. Cell Mol Life Sci 63 (2006) 1819-1822
5. Mae M., and Langel U. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr Opin Pharmacol 6 (2006) 509-514
6. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272 (1997) 16010-16017
7. Derossi D., Joliot A.H., Chassaing G., and Prochiantz A. The third helix of the antennapedia homeodomain translocates through biological membranes. J Biol Chem 14 (1994) 10444-10450
8. Elliott G., and O'Hare P. Intercellular trafficking and protein delivery by a herpes virus structural protein. Cell (Cambridge, MA, US) 88 (1997) 223-233
9. Deshayes S., Morris M.C., Divita G., and Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci 62 (2005) 1839-1849
10. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., and Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97 (2000) 13003-13008
11. Frackenpohl J., Arvidsson P.I., Schreiber J.V., and Seebach D. The outstanding biological stability of β- and γ-peptides toward proteolytic enzymes: an in vitro investigation with fifteen peptidases. Chem Bio Chem 2 (2001) 445-455
12. Umezawa N., Gelman M.A., Haigis M.C., Raines R.T., and Gellman S.H. Translocation of a β-peptide across cell membranes. J Am Chem Soc 124 (2002) 368-369
13. Wender P.A., Rothbard J.B., Jessop T.C., Kreider E.L., and Wylie B.L. Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery. J Am Chem Soc 124 (2002) 13382-13383
14. Fillon Y.A., Anderson J.P., and Chmielewski J. Cell penetrating agents based on a polyproline helix scaffold. J Am Chem Soc 127 (2005) 11798-11803
15. Geisler I., and Chmielewski J. Probing length effects and mechanism of cell penetrating agents mounted on a polyproline helix scaffold. Bioorg Med Chem Lett 17 (2007) 2765-2768
16. Potocky T.B., Menon A.K., and Gellman S.H. Effects of conformational stability and geometry of guanidinium display on cell entry by β-peptides. J Am Chem Soc 127 (2005) 3686-3687
17. Potocky T.B., Silvius J., Menon A.K., and Gellman S.H. HeLa cell entry by guanidinium-rich β-peptides: importance of specific cation-cell surface interactions. Chem Bio Chem 8 (2007) 917-926
18. Murray J.K., and Gellman S.H. Application of microwave irradiation to the synthesis of 14-helical β-peptides. Org Lett 7 (2005) 1517-1520
19. 3-amino acids and their use as building blocks for the solid-phase synthesis of β-peptides. Helv Chim Acta 81 (1998) 187-206
20. Vedel L., Bonke G., Foged C., Ziegler H., Franzyk H., Jaroszewski J.W., and Olsen C.A. Antiplasmodial and prehemolytic activities of α-peptide-β-peptoid chimeras. Chembiochem 8 (2007) 1781-1784
21. 47-57, a well-known cell-penetrating α-peptide.
22. Okuyama M., Laman H., Kingsbury S.R., Visintin C., Leo E., Eward K.L., Stoeber K., Boshoff C., Williams G.H., and Selwood D.L. Small-molecule mimics of an α-helix for efficient transport of proteins into cells. Nat Methods 4 (2007) 153-159. In this work Selwood and co-workers describe an elegant demonstration of how small molecules can efficiently mimic an α-helix, in this case to generate a very small cell penetrating peptide (CPP). The molecules reported are shown to deliver a variety of biomolecules to the interior of cells.
23. Jacoby E. Biphenyls as potential mimics of protein α-helix. Bioorg Med Chem Lett 12 (2002) 891-893
24. Kwon Y.U., and Kodadek T. Quantitative evaluation of the relative cell permeability of peptoids and peptides. J Am Chem Soc 129 (2007) 1508-1509. This paper describes a clever method to quantify the relative cell permeability of peptides and peptidomimetics such as peptoids. In this assay, the compound is conjugated to dexamethasone and incubated with a cell containing three plasmids. One of these harbors a Gal4 DNA-binding domain and a VP16 transactivation domain that is bound and activated by dexamethasone. The other two contain a Gal4-responsive firefly luciferase reporter gene and an independently expressed Renilla reniformis luciferase, respectively. The concentration of compound inside the cell is measured by quantifying the ratio of luciferase output from these two reporter plasmids.
25. Lim H.S., Archer C.T., and Kodadek T. Identification of a peptoid inhibitor of the proteasome 19S regulatory particle. J Am Chem Soc 129 (2007) 7750-7751. This study utilized a unique strategy of appending a purine analog to each member of a peptoid library to select for inhibitors of the 19S regulatory particle of the proteome. Significantly, the resulting compound was able to enter cells and antagonize 26S-mediated proteolytic degradation of the p27 protein.
26. Xiao X., Yu P., Lim H.-S., Sikder D., and Kodadek T. A cell-permeable synthetic transcription factor mimic. Angew Chem Int Ed 46 (2007) 2865-2868. A peptoid found to have high affinity for the KIX domain of the CREB-binding protein was linked to the known DNA-binding hairpin polyamide ImPy7 to generate a synthetic transcription factor mimic. This cell-permeable construct is the first of its class able to activate endogenous genes in live cells.
27. Xiao X., Yu P., Lim H.S., Sikder D., and Kodadek T. Design and synthesis of a cell-permeable synthetic transcription factor mimic. J Comb Chem 9 (2007) 592-600
28. Steer D.L., Lew R.A., Perlmutter P., Smith A.I., and Aguilar M.-I. β-amino acids. versatile peptidomimetics. Curr Med Chem 9 (2002) 811-822
29. 3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome. Mol Immunol 44 (2007) 3024-3036
30. L. The paper provides a complete series of experiments including alanine and hydrophile scanning that will likely prove useful for targeting other protein-binding pockets in a similar manner if a single scaffold does not suffice
31. L. Chem Bio Chem 8 (2007) 903-916
32. Kritzer J.A., Lear J.D., Hodsdon M.E., and Schepartz A. Helical β-peptide inhibitors of the p53-hdm2 interaction. J Am Chem Soc 126 (2004) 9468
33. Kritzer J.A., Leudtke N.W., Harker E.A., and Schepartz A. A rapid library screen for tailoring β-peptide structure and function. J Am Chem Soc 127 (2005) 14584
34. Stephens O.M., Kim S., Welch B.D., Hodsdon M.E., Kay M.S., and Schepartz A. Inhibiting HIV fusion with a β-peptide foldamer. J Am Chem Soc 127 (2005) 13126-13127
35. English E.P., Chumanov R.S., Gellman S.H., and Compton T. Rational development of β-peptide inhibitors of human cytomegalovirus entry. J Biol Chem 281 (2006) 2661-2667
36. 3-peptides by GalNAc specific lectins. J Mol Recogn 20 (2007) 132-138
37. Fujimura F., Horikawa Y., Morita T., Sugiyama J., and Kimura S. Double assembly composed of lectin association with columnar molecular assembly of cyclic tri-β-peptide having sugar units. Biomacromolecules 8 (2007) 611-616
38. Armand P., Kirshenbaum K., Goldsmith R.A., Farr-Jones S., Barron A.E., Truong K.T.V., Dill K.A., Mierke D.F., Cohen F.E., Zuckermann R.N., et al. NMR determination of the major solution conformation of a peptoid pentamer with chiral side chains. Proc Natl Acad Sci U S A 95 (1998) 4309-4314
39. Hara T., Durell S.R., Myers M.C., and Appella D.H. Probing the structural requirements of peptoids that inhibit hdm2-p53 interactions. J Am Chem Soc 128 (2006) 1995-2004. A peptoid previously identified as an inhibitor of the p53·hDM2 interaction was optimized to improve its solubility and binding properties, providing insight into the general considerations for designing peptoid inhibitors.
40. Alluri P.G., Reddy M., Sikder-Bachhawat K., Olivos H.J., and Kodadek T. Isolation of protein ligands from large peptoid libraries. J Am Chem Soc 125 (2003) 13995-14004
41. Mapp A.K., Ansari A.Z., Ptashne M., and Dervan P.B. Activation of gene expression by small molecule transcription factors. Proc Natl Acad Sci U S A 97 (2000) 3930-3935
42. Li X., Miltschitzky S., and Konig B. Luminescent pyrimidine hydrazide oligomers with peptide affinity. Bioorg Med Chem 14 (2006) 6075-6084
43. Orner B.P., Ernst J.T., and Hamilton A.D. Toward proteomimetics: terphenyl derivatives as structural and functional mimics of extended regions of an α-helix. J Am Chem Soc 123 (2001) 5382-5383
44. Becerril J., and Hamilton A.D. Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. Angew Chem Int Ed 46 (2007) 4471-4473. This work used a rigid biaryl scaffold designed to target the ligand-binding domain of the estrogen receptor by providing a mimic of the positioning of residues in a known coactivator protein. Competitive binding experiments demonstrated that the identified inhibitors could in fact compete directly with the coactivator for its binding site.
45. Tew G.N., Liu D., Chen B., Doerksen R.J., Kaplan J., Carroll P.J., Klein M.L., and DeGrado W.F. De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci U S A 99 (2002) 5110-5114
46. 1 integrin. A potent inhibitor identified through an ELISA assay was able to inhibit the interaction between the two proteins in cells and was shown to target an allosteric-binding site, providing an alternative strategy for targeting similar domains.
47. Yin H., Frederick K.K., Liu D., Wand A.J., and DeGrado W.F. Arylamide derivatives as peptidomimetic inhibitors of calmodulin. Org Lett 8 (2006) 223-225. The authors describe a group of arylamide derivatives designed to mimic a calmodulin-binding helical peptide. Fluorescence polarization and NMR experiments were used to demonstrate the inhibitory activity and binding site of the inhibitors.
48. Yin H., Slusky J.S., Berger B.W., Walters R.S., Vilaire G., Litvinov R.I., Lear J.D., Caputo G.A., Bennett J.S., and DeGrado W.F. Computational design of peptides that target transmembrane helices. Science (Washington, DC, US) 315 (2007) 1817-1822
49. Shin S.B.Y., Yoo B., Todaro L.J., and Kirshenbaum K. Cyclic peptoids. J Am Chem Soc 129 (2007) 3218-3225. Cyclic peptoids were prepared rapidly and in high efficiency with chain lengths ranging from 4 to 20 residues. The resulting structures revealed the ability of peptoids to assume reverse-turns similar to those found in natural peptides.
50. Pokorski J.K., Jenkins L.M.M., Feng H.Q., Durell S.R., Bai Y.W., and Appella D.H. Introduction of a triazole amino acid into a peptoid oligomer induces turn formation in aqueous solution. Org Lett 9 (2007) 2381-2383
51. 9 adopts a unique, hydrogen bond facilitated threaded-loop conformation in acetontrile, exemplifying the ability of peptoids to adopt complex three-dimensional structures.
52. * interactions regulate amide isomerism in the peptoid backbone. J. Am. Chem. Soc. 129 (2007) 8928-8929
53. Gorske B.C., and Blackwell H.E. Tuning peptoid secondary structure with pentafluoroaromatic functionality: A new design paradigm for the construction of discretely folded peptoid structures. J. Am. Chem. Soc. 128 (2006) 14378-14387. This work explored the role of pentafluoroaromatic side-chains in favoring peptoid helicity by destabilizing backbone hydrogen bonds. The ability to of this group to enhance π-stacking was dismissed in favor of its effect on backbone electrostatics.
54. 3-peptides by thioligation. Helv Chim Acta 85 (2002) 1812-1826
55. Raguse T.L., Lai J.R., LePlae P.R., and Gellman S.H. Toward β-peptide tertiary structure: Self-association of an amphiphilic 14-helix in aqueous solution. Org Lett 3 (2001) 3963-3966
56. Seebach D., Abele S., Gademann K., and Jaun B. Pleated sheets and turns of β-peptides with proteinogenic side chains. Angew Chem Int Ed 38 (1999) 1595-1597
57. 3hHis building blocks: Evidence from CD measurements. Helv Chim Acta 86 (2003) 2653-2661
58. 2 zinc finger proteins. Annu Rev Biophys Biomol Struct 29 (2000) 183-212
59. 2+. The design principles that are incorporated into this β-hexadecapeptide are a culmination of virtually all of the previous efforts directed at developing β-peptide structure.
60. Oshea E.K., Lumb K.J., and Kim P.S. Peptide velcro - design of a heterodimeric coiled-coil. Curr Biol 3 (1993) 658-667
61. 3-peptides that oligomerize in solution at micromolar concentrations and with a discrete, octameric stoichiometry.
62. Crick F.H.C. The packing of α-helices - simple coiled-coils. Acta Cryst 6 (1953) 689-697
63. 14-helix affects the packing of helices.
64. 3-peptide helical bundle as an octamer in solution.
65. Goodman JL, Petersson EJ, Daniels DS, Qiu JX, Schepartz A: Biophysical and structural characterization of a robust octameric β-peptide bundle. J Am Chem Soc 2007, in press.
66. Oshea E.K., Klemm J.D., Kim P.S., and Alber T. X-ray structure of the Gcn4 leucine zipper, a 2-stranded, parallel coiled coil. Science (Washington, DC, US) 254 (1991) 539-544
67. Karle I.L. Hydrogen bonds in molecular assemblies of natural, synthetic and 'designer' peptides. J Mol Struct 474 (1999) 103-112
68. Karle I.L., Gopi H.N., and Balaram P. Peptide hybrids containing α- and β-amino acids: Structure of a decapeptide β-hairpin with two facing β-phenylalanine residues. Proc Natl Acad Sci U S A 98 (2001) 3716-3719
69. Gopi H.N., Roy R.S., Raghothama S.R., Karle I.L., and Balaram P. β-hairpins generated from hybrid peptide sequences containing both α- and β-amino acids. Helv Chim Acta 85 (2002) 3313-3330
70. Roy R.S., Karle I.L., Raghothama S., and Balaram P. α, β hybrid peptides: A polypeptide helix with a central segment containing two consecutive β-amino acid residues. Proc Natl Acad Sci U S A 101 (2004) 16478-16482
71. Harbury P.B., Zhang T., Kim P.S., and Alber T. A switch between 2-stranded, 3-stranded and 4-stranded coiled coils in Gcn4 leucine-zipper mutants. Science (Washington, DC, US) 262 (1993) 1401-1407
72. Horne W.S., Price J.L., Keck J.L., and Gellman S.H. Helix bundle quaternary structure from α/β-peptide foldamers. J Am Chem Soc 129 (2007) 4178-4180. Mixed α/β-peptides designed to mimic natural helical bundles were shown to exhibit some level of quaternary structure via solution characterization and high-resolution structure.
73. Lumb K.J., and Kim P.S. A buried polar interaction imparts structural uniqueness in a designed heterodimeric coiled-coil. Biochemistry 34 (1995) 8642-8648
74. 3-, and cyclic β-amino acids on the ability to of the tetramer to form was explored.